Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease

​OBJECTIVE: Compared with hemoglobin A1c (HbA1c), continuous glucose monitoring (CGM) may better capture risk of diabetes complications in patients with chronic kidney disease (CKD), including diabetic peripheral neuropathy (DPN). We hypothesized that glucose time in range (TIR), measured by CGM, is...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayeda, Laura, Katz, Ronit, Ahmad, Iram, Bansal, Nisha, Batacchi, Zona, Hirsch, Irl B, Robinson, Nicole, Trence, Dace L, Zelnick, Leila, de Boer, Ian H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Pathophysiology/Complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039577/
https://www.ncbi.nlm.nih.gov/pubmed/31958307
http://dx.doi.org/10.1136/bmjdrc-2019-000991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039577/
https://www.ncbi.nlm.nih.gov/pubmed/31958307
http://dx.doi.org/10.1136/bmjdrc-2019-000991

Ejemplares similares